4 completed. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
Follow Type1diabetes: new trials by email Literature Review of Type1diabetes trials Research Report on Type1diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Butyrate Adjuvant Therapy for Type 1 Diabetes BKR-017 - Type1diabetes | Phase 1 / Phase 2 | Completed | Mayo Clinic | 6 | 2022-07-28 | 2026-03-31 |
| A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes YG1699, Dapagliflozin - Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Completed | Youngene Therapeutics Inc., Ltd. | 19 | 2021-06-17 | 2022-07-28 |
| Evaluation of Coffee Therapy for Improvement of Renal Oxygenation Starbucks® Cold brew - 325ml bottle - Type1diabetes, Type1 Diabetes Mellitus | Phase 2 | Completed | University of Colorado, Denver | 10 | 2019-07-01 | 2022-02-15 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes ProTrans, Control - Type1diabetes | Phase 1 / Phase 2 | Completed | NextCell Pharma Ab | 15 | 2019-05-17 | 2025-03-07 |
Diabetes Mellitus, Type 1 (3) · Diabetes Mellitus (2) · Diabetes Complications (1) · Diabetic Nephropathies (1)
Autoimmune Diseases (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Immune System Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Diabetes Mellitus (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Butyrates (1) · Transplantation, Homologous (1) · dapagliflozin (1)
Mayo Clinic (1) · NextCell Pharma Ab (1) · University of Colorado, Denver (1) · Youngene Therapeutics Inc., Ltd. (1)
United States (3) · Sweden (1)
Adrian Vella, MD (1) · Per-Ola Carlsson, PhD (1) · Petter Bjornstad, MD (1)
2018 (1)